Background: Other primary cancers (OPC) have been reported in gastric cancer (GC) patients. Recent studies have shown relationships of obesity and diabetes mellitus to cancer development in several organs. The purpose of this study was to investigate the relationships of obesity and diabetes mellitus (DM) to the prevalence of OPC in GC patients. Methods: We reviewed 435 GC patients who were treated surgically and followed their outcomes after surgery. Patients with body mass index (BMI) ! 25 kg/m 2 were defined as obese. Fasting plasma glucose (FPG) and HbA1c levels were examined before surgery. Results: OPC was observed in 109 GC patients (25.1%): 40 (9.2%) with synchronous OPC and 76 (18.2%) with metachronous OPC. The most common OPC was colorectal cancer (22.8%). OPC was frequently observed in patients with DM (p ¼ 0.0022), and DM was an independent risk factor for the occurrence of OPC (odds ratio, 2.215; 95% confidence interval, 1.2007e4.0850; p ¼ 0.011). Synchronous OPC was frequently observed in patients with obesity (p ¼ 0.025), and obesity was an independent risk factor for the occurrence of synchronous OPC (odds ratio, 2.354; 95% confidence interval, 1.1246e4.9279; p ¼ 0.023). Metachronous OPC was frequently observed in patients with DM (p ¼ 0.0071), and DM was an independent risk factor for the occurrence of OPC (odds ratio, 2.680; 95% confidence interval, 1.0291 e6.9780; p ¼ 0.044). Conclusion: There is a need to be aware of the possibility of OPC in GC patients with DM/obesity. They should undergo intensive screening for OPC before and after gastrectomy.
Introduction
Cancer screening using endoscopy and radical gastric resection with regional node dissection have improved the clinical outcomes of patients with gastric cancer (GC) [1, 2] . However, several issues remain for further improvement of the prognosis of GC patients. One of these major issues is synchronously and/or metachronously associated or secondary cancers in several organs. In 1932, Warren and Gates [3] described the concept of multiple primary malignant tumors, and such associations have been well investigated in all organs. Other primary cancers (OPC) in GC patients have previously been reported in many series [4e8] , and these studies reported an OPC incidence of 2.0e4.2 percent in GC patients [4,6e8] . However, it is well known that cancer incidence has gradually increased in many organs. "Synchronous cancers are detected more often than metachronous cancers. In pre-metachronous or post-metachronous cancer, the most common type was colorectal cancer, and in synchronous cancer, the most common type was liver cancer" [8] .
Obesity is an emerging risk factor for several cancers worldwide, and the relationships between obesity and cancers have been well investigated in many organs [9e11] . Increased body weight is associated with increased death rates for all cancers combined and for cancers at multiple specific sites [9] . Regarding cancers of the gastrointestinal tract, the relationship in colon cancer patients has been well investigated [12e14] . In addition, excess body weight has been associated with an increased risk of cardia gastric cancer, but this association is not found in non-cardia gastric cancer [15e17] . Furthermore, patients with obesity sometimes have diabetes mellitus (DM). DM is also a risk factor for several cancers, and the relationship between DM and colorectal cancers has been well investigated [18, 19] . DM patients also have a higher risk of GC [20, 21] and DM is associated with GC mortality [21] . However, there has been very little information regarding the relationship between multiple cancers/OPC and obesity/DM, and this relationship has yet to be investigated in GC patients.
The purpose of this study was to undertake a retrospective investigation of the relationships of obesity evaluated by body mass index (BMI) and DM to the prevalence of OPC in patients with surgically treated GC.
Patients and methods

Patients
A total of 435 consecutive patients with GC, who were treated between 2002 and 2010 in Shinshu University Hospital, were enrolled in the present study. According to the National Institutes of Health criteria, a BMI of 25.0e29.9 kg/m 2 is classified as overweight, and a BMI of 30.0 or greater is classified as obesity [22] . Usually, overweight patients with a BMI higher than 25.0 kg/m 2 are assessed as obese in Japan, as determined by the Japan Society for the Study of Obesity; 75 patients (17.2%) with a BMI higher than 25 kg/m 2 had obesity, and 360 patients (82.8%) with a BMI less than 25 kg/m 2 had normal body weight. The BMI was calculated from body weight and height at the time of diagnosis of gastric cancer. All patients were checked regarding DM; 47 patients had been treated previously for DM, and DM was newly diagnosed before surgery in 5 patients. In these 52 patients, DM was routinely controlled by physicians until elective surgery for GC, and there were no patients with type I DM. In GC patients, fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) levels were examined at the time before medical control of DM. Background data of GC patients with and without obesity are shown in Table 1 , and those with and without DM are shown in Table 2 . The operative method including distal gastrectomy, proximal gastrectomy, and total gastrectomy was determined according to the site of gastric cancer. In Stage II or III patients, S-1 was administered as adjuvant chemotherapy, but patients with severe comorbidity or aged 80 and more were excluded. In this series, there was no postoperative and hospital mortality in GC patients treated surgically.
Primary cancer arising from other organs was defined according to the criteria of Warren and Gates [3] . When two primary cancers were detected within one year, they were considered synchronous. When two primary cancers were not detected within one year, they were considered metachronous. Metachronous OPC included antecedent cancers before surgery for GC and subsequent cancers after surgery for GC. All OPC were evaluated histopathologically by taking a biopsy or resection. If the histopathological findings were similar, we used the immunostaining method. The patients with OPC consulted an expert in each field and were treated as appropriate.
The histopathologic findings of GC were obtained using resected specimens. The clinicopathologic features of GC were described according to the TNM classification (7th edition).
Other primary cancer screening before surgery
Before surgery for GC, we performed total colonoscopy when GC patients could have a meal, and we performed computed tomography (CT) of the whole body. Since 2005, 18 F-fluorodeoxyglucose positron-emission tomography (FDG-PET) of the whole body has been performed to stage gastric cancer and detect synchronous OPC.
Clinical outcome after surgery
After surgery, the gastric cancer patients were followed in the outpatient clinic of Shinshu University Hospital in order to check for the recurrence and metastasis of gastric cancer by esophagogastroduodenoscopy and CT of the whole body. Six months after operation, the patients were routinely checked by CT. One year after operation, CT and esophagogastroduodenoscopy were performed, and then CT and esophagogastroduodenoscopy were continued annually. Colonoscopy was performed 1 year after operation, and then every year in patients with colon neoplasm detected before and after surgery, and every 1e2 years in patients without colon neoplasm. From 2005, FDG-PET was performed to detect advanced gastric cancer preoperatively and once a year after operation to check for metastasis and to detect new tumors. Ninety-two (21.1%) patients underwent FDG-PET. If abnormalities were detected, the interval was reduced. All patients except for the terminally ill and those refusing the examinations underwent our surveillance program. These programs were continued until 5 years after operation. The median follow-up period was 39 months.
Statistical analysis
Data are shown as prevalence or mean and ordinal data were compared by the ManneWhitney test, and the Chi-square test or Fisher's exact probability test. Multivariate analysis of independent risk factors was carried out by multiple logistic regression tests. Survival rates after gastrectomy were calculated by the Kaplane Meier method. P < 0.05 was considered significant.
Results
Occurrence of OPC
Of 435 patients with GC, 109 patients (25.1%) had one or more OPC, giving a total of 127 OPC (Table 3 ). Forty GC patients (9.2%) had synchronous OPC, and 76 GC patients (17.5%) had metachronous OPC: 60 patients with antecedent OPC, 15 with subsequent OPC, and one with both types of metachronous OPC. The median interval between GC surgery and diagnosis of subsequent cancer was 24.5 months. OPC in the gastrointestinal tract was frequently observed, namely, in 34.9% of the patients with OPC. Additionally, adenomas in the colorectum were identified in 133 (30.6%) of the GC patients. Synchronous OPC was most frequently observed in the colorectum, while metachronous OPC was most frequently observed in the urogenital organs.
Comparison of patients with and without OPC
Regarding the clinicopathologic features of GC patients with and without OPC (Table 4) , OPC was frequently observed in elderly patients (p ¼ 0.001), patients with distant metastasis (p ¼ 0.02), and patients with DM (p ¼ 0.0022). We next analyzed age, distant metastasis, and DM, which had a significant impact on the occurrence of OPC, using multiple logistic regression tests. DM was an independent risk factor for the occurrence of OPC in GC patients ( Table 5 ).
Comparison of patients with and without synchronous OPC
Regarding the clinicopathologic features of GC patients with and without synchronous OPC (Table 4 ), synchronous OPC was frequently observed in men (p ¼ 0.0067) and obese patients (p ¼ 0.025). We next analyzed sex and obesity, which had a significant impact on the occurrence of synchronous OPC, using multiple logistic regression tests. Obesity was an independent risk factor for the occurrence of synchronous OPC in GC patients ( Table 5 ).
Comparison of patients with and without metachronous OPC
Regarding the clinicopathologic features of GC patients with and without metachronous OPC (Table 4 ), metachronous OPC was frequently observed in elderly patients (p ¼ 0.038), patients with habitual drinking (p ¼ 0.04), and patients with DM (p ¼ 0.0071). HbA1c level was significantly higher in patients with metachronous OPC than in those without it (p ¼ 0.0496). We next analyzed age, drinking, DM, and HbA1c, which had a significant impact on the occurrence of metachronous OPC, using multiple logistic regression tests. DM was an independent risk factor for the occurrence of metachronous OPC in GC patients ( Table 5 ). Among 60 patients with antecedent metachronous cancers, 14 patients had diabetes. All of them had been diagnosed with diabetes prior to the detection of antecedent metachronous cancer. The median period between the onset of diabetes and the detection of antecedent cancers was 24 months. There were no patients in whom diabetes was diagnosed after the detection of antecedent cancers.
Clinical outcome after surgery
There were no differences in overall survival after gastrectomy between GC patients with and without OPC (Fig. 1A) . The overall survival after gastrectomy in GC patients with synchronous OPC was significantly better than in those without it (p ¼ 0.04; Fig. 1B ), while there was no difference in the overall survival after gastrectomy between GC patients with and without metachronous OPC (Fig. 1C ). Furthermore, there was no difference in the overall survival after gastrectomy between GC patients with and without obesity (5-year survival rate, 74.0% vs. 72.6%; p ¼ 0.54), or with and without DM (5-year survival rate, 67.1% vs. 73.7%; p ¼ 0.57).
Discussion
Regarding OPC in GC patients, the incidence has previously been reported to be less than 5% [4, 6] ; however, a recent report showed an incidence of 20% [7] . We also detected an incidence of 25% in surgically treated GC patients. Therefore, intensive screening and follow-up are important for GC patients to detect OPC clinically. Colorectal cancer synchronously and metachronously associated with GC should be attended to in the management before and after gastric surgery because of its high frequency. Ikeda et al. [23] reported that colorectal cancer was detected most frequently after surgery in GC patients. We also demonstrated that colorectal cancers were observed in 6.7% of GC patients, and we suggest that colonoscopic examination may be useful for the detection of colorectal neoplasm in such patients. Our previous research [24] demonstrated a high incidence of colorectal adenoma in GC patients, so they should be surveyed for colon neoplasm more thoroughly than usual. Moreover, previous gastrectomy makes it difficult to perform surgery for colon cancer because of intraabdominal adhesion. Therefore, we performed colonoscopy for GC patients even without colon neoplasm at least every 2 years to avoid surgery caused by tumor progression. As metachronous OPC, cancers in the urogenital tract, including bladder and prostate cancers, should be attended to, given these results. However, other researchers did not demonstrate a high incidence of metachronous OPC in the urogenital tract in surgically treated GC patients. In Japan, recently, the incidence of prostate cancer has gradually increased [25] . The fact that the present study was performed in the last decade may have caused the results to differ from previous reports in terms of the incidence of OPC associated with GC. Although GC patients with OPC may have several issues, including in terms of postoperative outcomes, the long-term outcome after gastrectomy in GC patients with OPC was similar to that without OPC. The intensive check-up and follow-up for OPC, such as in the present study, may have influenced their similar outcomes in surgically treated GC patients.
Excess body weight is considered to be one of the risk factors of cancer incidence in several organs [16] . In the present study, obesity evaluated by BMI was an independent risk factor of synchronous OPC in GC patients. Furthermore, synchronous colorectal cancer was frequently associated with GC. It is well known that overweight or metabolic syndrome is related to the development of colorectal cancer [12, 13, 26, 27] , and DM is a risk factor of colorectal cancer [18, 19] . Hyperglycemia associated with insulin resistance also promotes the development of colorectal cancer [28, 29] . In other organs, an association between obesity and cancer development has been well investigated, and it has been found that many studies on the association between DM and cancer development have been influenced by the high prevalence of obesity in DM patients. In the present study, synchronous OPC was frequently observed in GC patients with obesity. Because many GC patients Fig. 1 . Overall survival curves. A. Between gastric cancer (GC) patients with and without other primary cancer (OPC), there was no difference in overall survival (p ¼ 0.3). The 5-year survival rates in GC patients with and without OPC were 66.1% and 75.2%, respectively. B. Between GC patients with and without synchronous OPC, there was a significant difference in overall survival. The 5-year survival rate in GC patients with synchronous OPC was poorer than in those without it (44.8% vs. 75.1%). C. Between GC patients with and without metachronous OPC, there was no difference in overall survival (p ¼ 0.76). The 5-year survival rates in GC patients with and without metachronous OPC were 68.5% and 74.0%, respectively. with obesity may exhibit these metabolic conditions, the possibility of synchronous OPC, especially colorectal cancer, may warrant intensive investigation before gastric surgery. However, metachronous (probably subsequent) OPC was not associated with obesity because many of the GC patients may improve in terms of excess body weight after gastrectomy.
Type 2-DM is not a single disease, but a group of metabolic disorders characterized by hyperglycemia. This metabolic disease group was an independent risk factor for the occurrence of OPC in GC patients, and GC patients with DM frequently showed obesity. FPG and HbA1c showed high levels in GC patients with DM before surgery, and these data were taken before sufficient control of DM for gastric surgery or treatment for newly detected DM. Although FPG and HbA1c levels were high in GC patients with OPC, the differences were not significant. This may have been due to the fact that this study population included GC patients with DM who had already been treated. Furthermore, there was no difference in HbA1c level in GC patients with and without synchronous OPC, while this level was higher in GC patients with metachronous OPC than in those without it. From these results, we suggest that metachronous OPC may frequently arise in GC patients with DM. It is considered that obesity and/or DM may be insufficiently controlled after treatment for antecedent OPC, and these conditions may also result from insufficient control of the metabolic situation after gastric surgery. However, we failed to demonstrate a high BMI in GC patients with OPC because DM had already been treated in some of the GC patients or BMI had decreased with the progression of DM status. Furthermore, many of the patients with type 2-DM are obese, and an association between DM and cancer incidence may be influenced by the high prevalence of obesity in DM patients. Not only DM but also obesity may be characterized by hyperglycemia, hyperinsulinemia, and a high incidence of OPC in GC patients.
As metachronous OPC in GC patients, we should attend to the urogenital tract as well as the lower digestive tract. Obesity has shown a weak association with prostate cancer incidence [30] , and the influence of obesity on bladder cancer has been poorly understood [31] . In contrast to the relationship of obesity to these cancers, Kasper et al. [32] reported a reduced risk of prostate cancer in men with DM, while Larsson et al. [33] reported an increased risk of bladder cancer in DM patients. DM is a multifactorial and chronic group of metabolic disorders characterized by hyperglycemia. Although DM is considered an increased risk for several cancers, organ-specific mechanisms may be important for cancer initiation or development. Regarding the association between GC and OPC in the urogenital tract, further investigation is necessary from the viewpoint of obesity and a hyperglycemic state.
Regarding the relationship between obesity and long-term outcome after surgery in GC patients, several researchers have demonstrated that obesity/overweight may correlate with the long-term outcome; however, this remains controversial. Some researchers reported that obesity was associated with a good prognosis in GC patients [34, 35] , while others reported that it was associated with a worse prognosis [36, 37] . Other groups demonstrated that it may not correlate with the prognosis of GC patients [38, 39] . Because, in the present study, neither obesity nor DM was correlated with the overall survival after gastrectomy for GC, these associations remain unresolved. Furthermore, the presence of OPC and metachronous OPC was not correlated with long-term outcome after surgery; however, GC patients with synchronous OPC had a worse outcome after surgery than those without it. Although obesity has been described as increasing the incidence of several complications after gastrectomy for GC in some reports [35, 38, 40] , other researchers reported that such a correlation was not observed [41, 42] . In the present study, GC patients with synchronous OPC frequently had obesity and postoperative complications. These factors may influence the long-term outcome after gastrectomy in GC patients with synchronous OPC. However, regardless of the presence of obesity and/or OPC, curative surgery may be appropriate for GC and/or OPC detected by intensive checkup because of a lack of mortality associated with gastrectomy and no difference in this regard between GC patients with OPC and metachronous OPC in this series.
Some reports described that there were significant differences in clinicopathological features such as tumor location between gastric cancer patients with and without OPC [43] . However, our results showed no differences in tumor location, depth of invasion, lymph node metastasis, and histologic type between cases with and without OPC, but they did indicate that diabetes was an independent risk factor of OPC, in addition to alcohol drinking. Smoking was associated with metachronous OPC in univariate analysis, although it was not significant in multivariate analysis. Diabetes management and lifestyle modification should be considered in gastric cancer patients.
There are several limitations of this study. First, the number of patients was small and this study was retrospective. Second, the OPCs had a wide variety in terms of malignant potential or type of treatment. This may be important for patient outcome. Third, our study period was insufficient to investigate subsequent cancer.
In conclusion, there is a need to be aware of the possibility of OPC in GC patients with DM/obesity. They should undergo intensive screening for OPC before and after gastrectomy.
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